One week left until the CDER SBIA extended webinar: Electronic Drug Registration & Listing Using CDER Direct – Oct. 5, 2017

FDA’s Center for Drug Evaluation and Research and Small Business and Industry Assistance (CDER SBIA) Regulatory Education for Industry (REdI) invites you to join us for our extended webinar: Electronic Drug Registration & Listing Using CDER Direct Thursday, October 5, 2017 Attend In-Person OR Virtually – both free of charge Advance registration is required Just in time for the registration renewal and the first required drug listing recertification period, this in-person and on-line event is intended to educate and assist all drug firms with the registration and listing process. Each session will focus on a specific submission (Establishment Registration, Product Listing, Listing Recertification, Labeler Code Requests, 503B Product Reporting) and walk through the creation and submission of each using FDA’s free authoring tool: CDER Direct. For those who attend in person, experts and helpdesk technicians will be on hand to answer regulatory and technical questions, and assist with submissions. When you register, you may choose to attend either on-site at the Tommy Douglas Conference Center (TDCC) or virtually online via Adobe Connect. We ask that you please honor your registration commitment. If you need to change your registration status, please email us at cancelation@SBIAevents.com. This 1 day webinar has been pre-approved by RAPS as eligible for up to 6 credits towards a participant’s RAC recertification upon full completion. For more information on CDER SBIA (866) 405-5367 | (301) 796-6707 | CDER Small Business and Industry Assistance (CDERSBIA@fda.hhs.gov)   CDER SBIA Learn If you've never used Connect Pro, get a quick overview: http://www.adobe.com/go/connectpro_overview Test your connection: https://collaboration.fda.gov/common/help/en/support/meeting_test.htm Adobe, the Adobe logo, Acrobat and Acrobat Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.